Literature DB >> 241455

Treatment of chronic obsessive-compulsive neurosis by in-vivo exposure. A two-year follow-up and issues in treatment.

I M Marks, R Hodgson, S Rachman.   

Abstract

Twenty patients with chronic obsessive-compulsive rituals were treated in a partially controlled design by in-vivo (real life) exposure with self-imposed response prevention. Treatment included 4-12 weeks as in-patients, and lasted a mean of 23 sessions. All patients were followed-up for at least two years. No patients dropped out during the trial, though one refused domiciliary treatment after discharge. Significant improvement in compulsions was found after three weeks of real-life exposure, and continued during follow-up. At two years follow-up 14 patients were much improved, one improved and 5 unchanged; in a third year of follow-up the improved patient became symptom-free after further exposure treatment. Improvement after three weeks exposure predicted good outcome at 6 and 12 months follow-up. Muscular relaxation treatment had no significant effect on rituals. Modelling of exposure conferred no advantage over exposure alone for the group as a whole, though it may help selected patients. The role of response prevention is unknown. Patients' commitment to treatment facilitates exposure. Domiciliary treatment with involvement of family members in therapy seems crucial in some cases. Pilot group treatment of patients and families together suggests that this may be a useful adjuvant to individual treatment by increasing motivation and aiding follow-up. Compulsive slowness presents special treatment problems but can be improved by a prompting and pacing approach. The course of rituals was often independent of that of agoraphobia, marital problems and depression where these had initially coexisted with rituals. Depressive episodes were common before, during and after treatment, and required tricyclic medication. The trial sample was predominantly female but was otherwise typical of patients with compulsive rituals. Of the 125 obsessive-compulsives seen in the first author's unit over four years 96 per cent were offered behavioural or anti-depressant treatment. One quarter refused behavioural treatment after it was offered. Real-life exposure with self-imposed response prevention is usually an effective procedure for lasting reduction of chronic compulsive rituals in well motivated patients.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 241455     DOI: 10.1192/bjp.127.4.349

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  13 in total

Review 1.  Obsessive compulsive disorder.

Authors:  G Mustafa Soomro
Journal:  BMJ Clin Evid       Date:  2012-01-18

2.  Challenges and Successes in Dissemination of Evidence-Based Treatments for Posttraumatic Stress: Lessons Learned From Prolonged Exposure Therapy for PTSD.

Authors:  Edna B Foa; Seth J Gillihan; Richard A Bryant
Journal:  Psychol Sci Public Interest       Date:  2013-05

Review 3.  Cognitive behavioral therapy for obsessive-compulsive disorder: an update.

Authors:  Jonathan D Huppert; Martin E Franklin
Journal:  Curr Psychiatry Rep       Date:  2005-08       Impact factor: 5.285

4.  A 2-year prospective follow-up study of the course of obsessive-compulsive disorder.

Authors:  Jane L Eisen; Anthony Pinto; Maria C Mancebo; Ingrid R Dyck; Maria E Orlando; Steven A Rasmussen
Journal:  J Clin Psychiatry       Date:  2010-08       Impact factor: 4.384

5.  Drug treatment of obsessive-compulsive disorder.

Authors:  P T Lelliott; W O Monteiro
Journal:  Drugs       Date:  1986-01       Impact factor: 9.546

6.  Behavioural approaches to anxiety disorders.

Authors:  L M Drummond
Journal:  Postgrad Med J       Date:  1993-03       Impact factor: 2.401

7.  Clomipramine in obsessive-compulsive ritualisers treated with exposure therapy: relations between dose, plasma levels, outcome and side effects.

Authors:  Y Kasvikis; I M Marks
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

8.  A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder.

Authors:  Helen Blair Simpson; Edna B Foa; Michael R Liebowitz; Deborah Roth Ledley; Jonathan D Huppert; Shawn Cahill; Donna Vermes; Andrew B Schmidt; Elizabeth Hembree; Martin Franklin; Raphael Campeas; Chang-Gyu Hahn; Eva Petkova
Journal:  Am J Psychiatry       Date:  2008-03-03       Impact factor: 18.112

9.  A time-limited behavioral group for treatment of obsessive-compulsive disorder.

Authors:  B L Van Noppen; M T Pato; R Marsland; S A Rasmussen
Journal:  J Psychother Pract Res       Date:  1998

10.  The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication.

Authors:  A M Ruscio; D J Stein; W T Chiu; R C Kessler
Journal:  Mol Psychiatry       Date:  2008-08-26       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.